Middle East respiratory syndrome (MERS-CoV)

Middle East respiratory syndrome (MERS-CoV)

outbreak

Overview

Middle East respiratory syndrome coronavirus (MERS-CoV) is a virus transferred to humans from infected dromedary camels. It is a zoonotic virus, meaning it is transmitted between animals and people, and it is contractable through direct or indirect contact with infected animals. MERS-CoV has been identified in dromedaries in several countries in the Middle East, Africa and South Asia. In total, 27 countries have reported cases since 2012, leading to 858 known deaths due to the infection and related complications.

The origins of the virus are not fully understood but according to the analysis of different virus genomes it is believed that it may have originated in bats and later transmitted to camels.

Human-to-human transmission is possible, but only a few such transmissions have been found among family members living in the same household. In health care settings, however, human-to-human transmission appears to be more frequent.

 

 

Publications

All →
Middle East respiratory syndrome: global summary and assessment of risk - 16 November 2022
Between 2012 and 17 October 2022, 2600 laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection have been reported...
Severe Acute Respiratory Infections Treatment Centre

This is the first edition of the practical manual to set up and manage a severe acute respiratory infection (SARI) treatment centre and a SARI screening...

Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection

This guidance is intended for health-care workers (HCWs), health-care managers, and IPC teams. Specific WHO interim guidance on Clinical Management of...

The protocol provides health care and public health professionals guidance on how to investigate the role of environmental contamination during outbreaks...

Cross-sectional seroepidemiologic study of MERS-CoV infection in high risk populations in contact with dromedary camels

This study protocol outlines methods to collect data to measure the seroprevalence of cross-reactive antibodies to MERS-CoV in presumed high-risk human...

Cross-sectional seroepidemiologic study of MERS-CoV infection in high-risk populations in contact with dromedary camels

Representative serologic studies are designed to collect data to estimate prevalence of antibodies to a new pathogen in a population. This information...